Reviewed by Jonathan Teplitsky · Updated September 2026 · Informational only — not legal or medical advice; Rank and Pay is not affiliated with the VA.
The Department of Veterans Affairs (VA) assigns a disability rating for psoriasis at 0, 10, 30, or 60 percent under Diagnostic Code (DC) 7816. Ratings reflect either total skin coverage or the extent of systemic therapy required over the prior 12 months. Joint complications are evaluated separately under musculoskeletal codes rather than combined into the skin percentage.
Rating Percentages Under Diagnostic Code 7816
The VA evaluates psoriasis under Diagnostic Code (DC) 7816 in Title 38 of the Code of Federal Regulations (CFR) § 4.118 by applying the rating criteria established for dermatitis and eczema. These criteria establish two independent paths to establish a rating: the extent of body surface area involved or the duration of systemic therapy in the preceding 12 months. When both metrics apply, the VA assigns the higher of the two percentages.
The rating schedule establishes four distinct percentage levels:
- 0 percent rating: Less than 5 percent of the entire body or less than 5 percent of exposed areas affected, requiring no more than topical therapy over the prior 12 months.
- 10 percent rating: At least 5 percent but less than 20 percent of the entire body or exposed areas affected, or intermittent systemic therapy for a total of less than six weeks in the prior 12 months.
- 30 percent rating: 20 percent to 40 percent of the entire body or exposed areas affected, or systemic therapy for six weeks or more (but not constant) in the prior 12 months.
- 60 percent rating: More than 40 percent of the entire body or exposed areas affected, or constant or near-constant systemic therapy in the prior 12 months.
Exposed areas include the head, face, neck, and hands. Coverage of 15 percent across these regions qualifies for a 10 percent rating even with an unaffected torso. Claimants can assess how multiple disability percentages combine using the VA disability rating calculator.
Clinical Symptoms and Diagnostic Standards for Psoriasis
Psoriasis is a chronic autoimmune condition that accelerates skin cell production, creating thick, raised patches covered with silvery scales. These raised plaques appear on the elbows, knees, scalp, and lower back. Patients commonly experience burning sensations, severe itching, skin fissures, and bleeding during active flare episodes.
Establishing a successful claim requires a formal medical diagnosis documented by a qualified healthcare professional. Notes that describe unspecified rash, itching, or hives without a formal diagnosis do not satisfy evidentiary requirements. A conclusive diagnosis relies on physical examinations, clinical histories, and occasionally skin biopsies to distinguish psoriasis from other skin conditions.
Treatment Categories and Their Impact on Disability Ratings
The VA rating schedule differentiates between topical treatments and systemic therapies when assigning disability percentages under DC 7816. Topical treatments consist of medicated creams, localized corticosteroids, and coal tar products applied directly to affected lesions. These topical agents alone cannot produce an evaluation above 0 percent unless the total body surface area meets the higher percentage thresholds.
Systemic treatments work internally throughout the body and include oral corticosteroids, traditional immunosuppressive drugs, and injectable biologic agents. The VA measures systemic therapy by calculating cumulative administration time over the previous 12 months. Intermittent therapy lasting under six weeks supports a 10 percent rating, six weeks or more warrants 30 percent, and continuous administration results in 60 percent.
Prescription records serve as essential objective evidence for the systemic treatment prong. Claimants should retain detailed pharmacy records, prescribing physician notes, and administration schedules. A lapse in documented medication refills during the 12-month period can lead an adjudicator to assign a lower evaluation.
Independent Disability Ratings for Psoriatic Arthritis
The VA rates psoriatic arthritis as an independent musculoskeletal disability under 38 CFR § 4.71a rather than combining it into the skin percentage under DC 7816. Approximately thirty percent of individuals diagnosed with psoriasis also experience inflammatory joint disease. Skin symptoms and joint inflammation constitute distinct medical conditions under federal disability regulations.
Filing a claim for skin psoriasis alone does not trigger an evaluation for joint limitations. Claimants with joint stiffness, persistent swelling, or limited mobility must file an explicit claim for psoriatic arthritis. The VA rates each affected joint individually based on limited range of motion, painful motion, and structural damage under the rules for arthritis.
Joint ratings provide additional monthly compensation on top of the skin rating under DC 7816. For example, a veteran might receive 30 percent for skin plaques and separate 10 percent ratings for both knees. These distinct ratings are combined using VA math rather than added directly together.
Direct Service Connection for Psoriasis Claims
Direct service connection requires objective evidence that psoriasis originated during active military duty. Claimants must satisfy three statutory requirements under VA disability eligibility rules: an in-service occurrence, a current diagnosis, and a medical nexus. Service medical treatment records documenting skin clinic visits, prescription ointments, or recurring rashes establish the in-service component.
Initial symptoms during military service are sometimes recorded under preliminary labels such as contact dermatitis or eczema. A qualified dermatologist can review historic service treatment records and link those early skin eruptions to current chronic psoriasis. A detailed medical statement bridging service events to modern medical records provides the necessary nexus.
Claimants can structure this supporting evidence using the framework outlined in the nexus letter guide. Strong medical opinions quote specific military medical entries and provide clinical reasoning supporting the connection. Personal statements describing uninterrupted flare cycles since discharge also help substantiate continuity of symptomatology.
Secondary Service Connection and Documented Stress Triggers
Psoriasis can be service-connected on a secondary basis when an established service-connected disability causes, worsens, or accelerates the autoimmune disease. Secondary claims follow the legal standards for secondary conditions, requiring proof of a primary service-connected condition and an explanatory medical nexus. Autoimmune conditions frequently react to severe physiological and psychological stress.
Severe psychological stress triggers psoriasis flare episodes in patients with an underlying autoimmune condition. Veterans with service-connected Post-Traumatic Stress Disorder (PTSD) or chronic anxiety frequently report severe skin exacerbations during acute mental health crises. Increased systemic inflammation during trauma responses can accelerate skin cell turnover and aggravate existing plaques.
Secondary service connection is not granted automatically for veterans with PTSD. The claim requires a formal nexus opinion from a dermatologist or treating physician explaining how psychiatric distress intensifies the psoriasis flare cycle. The medical expert must explain the biological mechanism linking chronic psychiatric stress to cutaneous flare frequency.
Absence of Presumptive Service Connection for Psoriasis
Psoriasis has no presumptive service connection status under the PACT Act or Agent Orange exposure regulations. Veterans who served near burn pits or in areas with herbicide application cannot rely on statutory exposure presumptions to establish their claims. Every claim must establish causation through direct in-service records or secondary medical nexus evidence.
While federal law provides presumptive status for respiratory diseases and specific cancers, autoimmune skin conditions remain excluded. Claimants alleging toxic exposure must provide medical literature and doctor opinions connecting their specific exposure history to their autoimmune onset. Reviewing the standard criteria for dermatitis and eczema illustrates how non-presumptive skin conditions are adjudicated.
Compensation and Pension Examination Procedures
A Compensation and Pension (C&P) examination for psoriasis evaluates the surface area of skin involvement and reviews 12 months of treatment records. The examining clinician inspects the body to quantify total plaque coverage across the torso, limbs, and exposed regions. Examiners calculate body surface area using anatomical charts or the palm method, where a hand represents roughly one percent of body surface.
Claimants should present thorough documentation of both topical and systemic therapies at the examination. The examiner must record the exact medication names, dosages, and cumulative weeks of administration over the preceding year. Systemic immunosuppressive therapies must be clearly distinguished from standard topical creams in the examiner's report.
Because psoriasis symptoms fluctuate over time, skin may appear clear on the specific day of a C&P exam. Claimants should submit clear, dated photographs taken during peak flare cycles to document active plaque severity. Dermatologist treatment logs recording flare frequency also provide essential context when an exam coincides with a temporary remission.
Reassessments and Rating Adjustments Over Time
The VA determines disability ratings for psoriasis based strictly on the most recent 12-month period of medical history. An existing disability rating can increase, decrease, or remain unchanged whenever updated clinical evidence or a re-evaluation occurs. Changes in medication type or healing skin plaques directly affect the applicable percentage tier.
A reduction can occur if a veteran transitions off systemic immunosuppressive therapy onto topical treatments alone. When systemic therapy ceases and plaque coverage falls below 20 percent, the regulatory criteria no longer support a 30 or 60 percent rating. The VA must follow formal due process procedures before reducing an established service-connected rating.
Conversely, veterans experiencing worsening disease progression can file a claim for an increased rating. If topical ointments fail and a physician initiates six or more weeks of systemic therapy, the medical evidence warrants a step up to 30 percent. Tracking continuous pharmacy records and dermatologist notes provides the evidentiary trail needed to substantiate a higher rating.
Evidence Gathering for a Psoriasis VA Rating
Submitting a well-documented claim file prevents delays and helps secure an accurate psoriasis VA rating. Claimants should compile civilian dermatology records, military treatment logs, prescription history receipts, and photographic evidence before submitting paperwork to the VA. Veterans preparing a claim should compile their 12-month treatment logs, photographs, and medical records to pursue an accurate psoriasis va rating.
This page is informational only and is not legal or medical advice. Rank and Pay is not affiliated with the Department of Veterans Affairs. Rating criteria are summarized from 38 CFR Part 4; for your specific claim, consult the VA, an accredited Veterans Service Officer (VSO), or an accredited attorney.